- Home
- RVPH vs DTSQ Comparison
RVPH vs DTSQ Comparison
Compare RVPH & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- DTSQ
- Stock Information
- Founded
- RVPH 2006
- DTSQ 2022
- Country
- RVPH United States
- DTSQ United States
- Employees
- RVPH N/A
- DTSQ N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- DTSQ
- Sector
- RVPH Health Care
- DTSQ
- Exchange
- RVPH Nasdaq
- DTSQ NYSE
- Market Cap
- RVPH 88.0M
- DTSQ 89.8M
- IPO Year
- RVPH N/A
- DTSQ 2024
- Fundamental
- Price
- RVPH $1.11
- DTSQ $10.21
- Analyst Decision
- RVPH Strong Buy
- DTSQ
- Analyst Count
- RVPH 5
- DTSQ 0
- Target Price
- RVPH $11.40
- DTSQ N/A
- AVG Volume (30 Days)
- RVPH 1.2M
- DTSQ 53.1K
- Earning Date
- RVPH 04-14-2025
- DTSQ 01-01-0001
- Dividend Yield
- RVPH N/A
- DTSQ N/A
- EPS Growth
- RVPH N/A
- DTSQ N/A
- EPS
- RVPH N/A
- DTSQ 0.17
- Revenue
- RVPH N/A
- DTSQ N/A
- Revenue This Year
- RVPH N/A
- DTSQ N/A
- Revenue Next Year
- RVPH N/A
- DTSQ N/A
- P/E Ratio
- RVPH N/A
- DTSQ $61.44
- Revenue Growth
- RVPH N/A
- DTSQ N/A
- 52 Week Low
- RVPH $0.60
- DTSQ $9.96
- 52 Week High
- RVPH $4.28
- DTSQ $10.37
- Technical
- Relative Strength Index (RSI)
- RVPH 29.15
- DTSQ N/A
- Support Level
- RVPH $1.12
- DTSQ N/A
- Resistance Level
- RVPH $1.35
- DTSQ N/A
- Average True Range (ATR)
- RVPH 0.14
- DTSQ 0.00
- MACD
- RVPH -0.03
- DTSQ 0.00
- Stochastic Oscillator
- RVPH 5.17
- DTSQ 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.